Trial Profile
Supporting the health of adults undergoing orthopedic surgery during the recovery period
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 04 Jun 2015
Price :
$35
*
At a glance
- Drugs Donepezil (Primary)
- Indications Delirium
- Focus Adverse reactions
- Acronyms SHARP
- 07 Apr 2011 Planned end date changed from 1 Aug 2009 to 1 Aug 2011 as reported by ClinicalTrials.gov.
- 02 Sep 2009 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov
- 02 Sep 2009 Planned end date changed from 1 Aug 2008 to 1 Aug 2009 as reported by ClinicalTrials.gov